118 related articles for article (PubMed ID: 17654023)
1. Controlled release of pranoprofen from the ethylene-vinyl acetate matrix using plasticizer.
Cho CW; Choi JS; Shin SC
Drug Dev Ind Pharm; 2007 Jul; 33(7):747-53. PubMed ID: 17654023
[TBL] [Abstract][Full Text] [Related]
2. Controlled release of furosemide from the ethylene-vinyl acetate matrix.
Cho CW; Choi JS; Shin SC
Int J Pharm; 2005 Aug; 299(1-2):127-33. PubMed ID: 15967605
[TBL] [Abstract][Full Text] [Related]
3. Enhanced controlled release of loratadine from the ethylene-vinyl acetate matrix containing plasticizer.
Cho CW; Kim SJ; Yang KH; Song JH; Jeong HJ; Shin SC
Drug Deliv; 2008 Sep; 15(7):423-8. PubMed ID: 18712619
[TBL] [Abstract][Full Text] [Related]
4. Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen-ethylene-vinyl acetate matrix containing penetration enhancer in rats.
Cho CW; Choi JS; Yang KH; Shin SC
Arch Pharm Res; 2009 May; 32(5):747-53. PubMed ID: 19471890
[TBL] [Abstract][Full Text] [Related]
5. Controlled release of triprolidine using ethylene-vinyl acetate membrane and matrix systems.
Shin SC; Lee HJ
Eur J Pharm Biopharm; 2002 Sep; 54(2):201-6. PubMed ID: 12191692
[TBL] [Abstract][Full Text] [Related]
6. Release characteristics of quinupramine from the ethylene-vinyl acetate matrix.
Kim J; Kim WJ; Kim SJ; Cho CW; Shin SC
Int J Pharm; 2006 Jun; 315(1-2):134-9. PubMed ID: 16644151
[TBL] [Abstract][Full Text] [Related]
7. Controlled release of atenolol from the ethylene-vinyl acetate matrix.
Kim J; Shin SC
Int J Pharm; 2004 Apr; 273(1-2):23-7. PubMed ID: 15010126
[TBL] [Abstract][Full Text] [Related]
8. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix.
Cho CW; Choi JS; Yang KH; Shin SC
Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Controlled Transdermal Delivery of Mexazolam Using Ethylene-vinyl Acetate.
Weon Cho C; Chul Shin S
Iran J Pharm Res; 2012; 11(1):3-12. PubMed ID: 25317180
[TBL] [Abstract][Full Text] [Related]
10. Enhanced transdermal delivery of pranoprofen from the bioadhesive gels.
Shin SC; Cho CW
Arch Pharm Res; 2006 Oct; 29(10):928-33. PubMed ID: 17121190
[TBL] [Abstract][Full Text] [Related]
11. Peculiar effect of polyethylene glycol in comparison with triethyl citrate or diethyl phthalate on properties of ethyl cellulose microcapsules containing propranolol hydrochloride in process of emulsion-solvent evaporation.
Afrasiabi Garekani H; Sanadgol N; Dehghan Nayyeri N; Nokhodchi A; Sadeghi F
Drug Dev Ind Pharm; 2018 Mar; 44(3):421-431. PubMed ID: 29098888
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of pranoprofen gel for percutaneous administration.
Choi JS; Shin SC
Drug Dev Ind Pharm; 2007 Jan; 33(1):19-26. PubMed ID: 17192247
[TBL] [Abstract][Full Text] [Related]
13. The influence of plasticizer on heat-humidity curing of cellulose acetate phthalate coated beads.
Williams RO; Liu J
Pharm Dev Technol; 2001 Nov; 6(4):607-19. PubMed ID: 11775961
[TBL] [Abstract][Full Text] [Related]
14. Sustained release from hot-melt extruded matrices based on ethylene vinyl acetate and polyethylene oxide.
Almeida A; Brabant L; Siepmann F; De Beer T; Bouquet W; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2012 Nov; 82(3):526-33. PubMed ID: 22986082
[TBL] [Abstract][Full Text] [Related]
15. Effects of solubilizing surfactants and loading of antiviral, antimicrobial, and antifungal drugs on their release rates from ethylene vinyl acetate copolymer.
Tallury P; Randall MK; Thaw KL; Preisser JS; Kalachandra S
Dent Mater; 2007 Aug; 23(8):977-82. PubMed ID: 17049593
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Controlled Transdermal Delivery of Ambroxol from the EVA Matrix.
Cho CW; Kim DB; Cho HW; Shin SC
Indian J Pharm Sci; 2012 Mar; 74(2):127-32. PubMed ID: 23325993
[TBL] [Abstract][Full Text] [Related]
17. Influence of plasticizer type and level on the properties of Eudragit S100 matrix pellets prepared by hot-melt extrusion.
Schilling SU; Lirola HL; Shah NH; Waseem Malick A; McGinity JW
J Microencapsul; 2010; 27(6):521-32. PubMed ID: 20575612
[TBL] [Abstract][Full Text] [Related]
18. Application of TPX polymer membranes for the controlled release of triprolidine.
Shin SC; Yoon MK
Int J Pharm; 2002 Jan; 232(1-2):131-7. PubMed ID: 11790496
[TBL] [Abstract][Full Text] [Related]
19. Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration.
Abrego G; Alvarado H; Souto EB; Guevara B; Bellowa LH; Parra A; Calpena A; Garcia ML
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):261-70. PubMed ID: 25681744
[TBL] [Abstract][Full Text] [Related]
20. Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate.
Tallury P; Alimohammadi N; Kalachandra S
Dent Mater; 2007 Apr; 23(4):404-9. PubMed ID: 16556460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
